Format

Send to

Choose Destination
J Anaesthesiol Clin Pharmacol. 2018 Oct-Dec;34(4):548. doi: 10.4103/joacp.JOACP_155_18.

Response to: "Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis".

Author information

1
Global Medical Affairs, Pfizer Inc., New York, NY, USA.
2
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA.
3
Formerly of Pfizer Global Research and Development (Rinat), Pfizer Inc., South San Francisco, California, USA.

Comment on

Conflict of interest statement

Leslie Tive is a full-time employee of, and own stock and/or stock options in, Pfizer Inc. David Shelton is a consultant for, and owns stock in, Pfizer Inc. Lars Viktrup is a full-time employee of, and owns stock and/or stock options in, Eli Lilly & Company.

Publication type

Publication type

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center